Literature DB >> 23292944

Novel method to differentiate 3T3 L1 cells in vitro to produce highly sensitive adipocytes for a GLUT4 mediated glucose uptake using fluorescent glucose analog.

Divya Vishwanath1, Harini Srinivasan, Manjunath S Patil, Sowmya Seetarama, Sachin Kumar Agrawal, M N Dixit, Kakali Dhar.   

Abstract

Adipocytes play a vital role in glucose metabolism. 3T3 L1 pre adipocytes after differentiation to adipocytes serve as excellent in vitro models and are useful tools in understanding the glucose metabolism. The traditional approaches adopted in pre adipocyte differentiation are lengthy exercises involving the usage of IBMX and Dexamethasone. Any effort to shorten the time of differentiation and quality expression of functional differentiation in 3T3 L1 cells in terms of enhanced Insulin sensitivity has an advantage in the drug discovery process. Thus, there is a need to develop a new effective method of differentiating the pre adipocytes to adipocytes and to use such methods for developing efficacious therapeutic molecules. We observed that a combination of Dexamethasone and Troglitazone generated differentiated adipocytes over fewer days as compared to the combination of IBMX and Dexamethasone which constitutes the standard protocol followed in our laboratory. The experiments conducted to compare the quality of differentiation yielded by various differentiating agents indicated that the lipid droplet accumulation increased by 112 % and the GLUT4 mediated glucose uptake by 137 % in cells differentiated with Troglitazone and Dexamethasone than in cells differentiated traditionally. The comparative studies conducted for evaluating efficient measurable glucose uptake by GOPOD assay, radioactive (3)H-2-deoxy-D-glucose assay and by non-radioactive 6-NBDG (fluorescent analog of glucose) indicated that the non-radioactive method using 6-NBDG showed a higher signal to noise ratio than the conventional indirect glucose uptake method (GOPOD assay) and the radioactive (3)H-2-deoxy-D-glucose uptake method. Differentiated 3T3 L1 cells when triggered with 2.5 ng/mL of Insulin showed 3.3 fold more glucose uptake in non-radioactive method over the radioactive (3)H-2-deoxy-D-glucose uptake method. The results of this study have suggested that a combination of Dexamethasone and Troglitazone for 3T3 L1 cell differentiation helps in better quality differentiation over a short period of time with increased sensitivity to Insulin. The application of these findings for developing new methods of screening novel Insulin mimetics and for evaluating the immunological responses has been discussed.

Entities:  

Year:  2013        PMID: 23292944      PMCID: PMC3660688          DOI: 10.1007/s12079-012-0188-9

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  31 in total

1.  Dexamethasone signaling is required to establish the postmitotic state of adipocyte development.

Authors:  E C Shugart; R M Umek
Journal:  Cell Growth Differ       Date:  1997-10

2.  Optimization of in vitro conditions for bovine subcutaneous and intramuscular preadipocyte differentiation.

Authors:  A C Grant; G Ortiz-Colòn; M E Doumit; D D Buskirk
Journal:  J Anim Sci       Date:  2007-10-02       Impact factor: 3.159

3.  Kinetic validation of 6-NBDG as a probe for the glucose transporter GLUT1 in astrocytes.

Authors:  Luis Felipe Barros; Carla X Bittner; Anitsi Loaiza; Iván Ruminot; Valeria Larenas; Hans Moldenhauer; Carolina Oyarzún; Mauro Alvarez
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

Review 4.  Adipocyte differentiation: a transcriptional regulatory cascade.

Authors:  R P Brun; J B Kim; E Hu; S Altiok; B M Spiegelman
Journal:  Curr Opin Cell Biol       Date:  1996-12       Impact factor: 8.382

5.  Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells.

Authors:  C S Rubin; A Hirsch; C Fung; O M Rosen
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

6.  Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation.

Authors:  D Shao; M A Lazar
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

Review 7.  Molecular mechanisms of insulin-stimulated glucose uptake in adipocytes.

Authors:  P-H Ducluzeau; L M Fletcher; H Vidal; M Laville; J M Tavaré
Journal:  Diabetes Metab       Date:  2002-04       Impact factor: 6.041

8.  Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O.

Authors:  J L Ramírez-Zacarías; F Castro-Muñozledo; W Kuri-Harcuch
Journal:  Histochemistry       Date:  1992-07

9.  CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program.

Authors:  F T Lin; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  Asymmetric transport of a fluorescent glucose analogue by human erythrocytes.

Authors:  L Speizer; R Haugland; H Kutchai
Journal:  Biochim Biophys Acta       Date:  1985-04-26
View more
  12 in total

1.  1,25(OH)2-vitamin D3 upregulates glucose uptake mediated by SIRT1/IRS1/GLUT4 signaling cascade in C2C12 myotubes.

Authors:  Prasenjit Manna; Arunkumar E Achari; Sushil K Jain
Journal:  Mol Cell Biochem       Date:  2017-11-29       Impact factor: 3.396

2.  Triphenyl phosphate enhances adipogenic differentiation, glucose uptake and lipolysis via endocrine and noradrenergic mechanisms.

Authors:  German Cano-Sancho; Anna Smith; Michele A La Merrill
Journal:  Toxicol In Vitro       Date:  2017-02-03       Impact factor: 3.500

3.  IL-25 directly modulates adipocyte function and inflammation through the regulation of adiponectin.

Authors:  Siranart Jeerawattanawart; Pilaiwan Siripurkpong; Sittiruk Roytrakul; Pornpimon Angkasekwinai
Journal:  Inflamm Res       Date:  2022-07-12       Impact factor: 6.986

4.  On being the right size: scaling effects in designing a human-on-a-chip.

Authors:  Christopher Moraes; Joseph M Labuz; Brendan M Leung; Mayumi Inoue; Tae-Hwa Chun; Shuichi Takayama
Journal:  Integr Biol (Camb)       Date:  2013-09       Impact factor: 2.192

5.  Metformin downregulates miR223 expression in insulin-resistant 3T3L1 cells and human diabetic adipose tissue.

Authors:  Yousof Naghiaee; Reza Didehdar; Fatemeh Pourrajab; Masoud Rahmanian; Naeime Heiranizadeh; Azra Mohiti; Javad Mohiti-Ardakani
Journal:  Endocrine       Date:  2020-09-24       Impact factor: 3.633

6.  Carnosic Acid Attenuates an Early Increase in ROS Levels during Adipocyte Differentiation by Suppressing Translation of Nox4 and Inducing Translation of Antioxidant Enzymes.

Authors:  Dae-Kun Lee; Hae-Dong Jang
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

7.  Rhinacanthins-rich Extract Enhances Glucose Uptake and Inhibits Adipogenesis in 3T3-L1 Adipocytes and L6 Myotubes.

Authors:  Muhammad Ajmal Shah; Chanawee Jakkawanpitak; Decha Sermwittayawong; Pharkphoom Panichayupakaranant
Journal:  Pharmacogn Mag       Date:  2018-01-31       Impact factor: 1.085

Review 8.  Cell Models and Their Application for Studying Adipogenic Differentiation in Relation to Obesity: A Review.

Authors:  Francisco Javier Ruiz-Ojeda; Azahara Iris Rupérez; Carolina Gomez-Llorente; Angel Gil; Concepción María Aguilera
Journal:  Int J Mol Sci       Date:  2016-06-30       Impact factor: 5.923

9.  The Gintonin-Enriched Fraction of Ginseng Regulates Lipid Metabolism and Browning via the cAMP-Protein Kinase a Signaling Pathway in Mice White Adipocytes.

Authors:  Kippeum Lee; Heegu Jin; Sungwoo Chei; Hyun-Ji Oh; Sun-Hye Choi; Seung-Yeol Nah; Boo-Yong Lee
Journal:  Biomolecules       Date:  2020-07-15

10.  A colorimetric bioassay for quantitation of both basal and insulin-induced glucose consumption in 3T3-L1 adipose cells.

Authors:  Paola A Rivera Diaz; Doris E Gómez Camargo; Alejandro Ondo-Méndez; Claudio J Gómez-Alegría
Journal:  Heliyon       Date:  2020-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.